The Time for Generics is Now

Although it may seem that the debate on generics is over, they still have a lot to offer in terms of healthcare savings. Medicines for Europe expects to increase from $168 billion in the world in 2013 to $283 billion in 2018.

The use of generic drugs in Spain has remained at 40% for the past 2 years, sitting well below the 56% average across Europe and is not expected progress without further regulatory measures.

Read the original article here.

Tagged with

Published 26. December 2016 in News Spain